Display options
Cite
Tasić D, Radenkovic S, Stojanovic D, et al. Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes. Cardiorenal Med. 2015;6(2):99-107doi: 10.1159/000437309.
Tasić, D., Radenkovic, S., Stojanovic, D., Milojkovic, M., Stojanovic, M., Ilic, M. D., & Kocic, G. (2016). Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes. Cardiorenal medicine, 6(2), 99-107. https://doi.org/10.1159/000437309
Tasić, Danijela, et al. "Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes." Cardiorenal medicine vol. 6,2 (2016): 99-107. doi: https://doi.org/10.1159/000437309
Tasić D, Radenkovic S, Stojanovic D, Milojkovic M, Stojanovic M, Ilic MD, Kocic G. Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes. Cardiorenal Med. 2016 Feb;6(2):99-107. doi: 10.1159/000437309. Epub 2015 Nov 11. PMID: 26989395; PMCID: PMC4789923.
Copy Download .nbib Format: NLM
Share it on

Cardiorenal Med. 2016 Feb;6(2):99-107. doi: 10.1159/000437309. Epub 2015 Nov 11.

Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes.

Cardiorenal medicine

Danijela Tasić, Sonja Radenkovic, Dijana Stojanovic, Maja Milojkovic, Miodrag Stojanovic, Marina Deljanin Ilic, Gordana Kocic

Affiliations

  1. Clinic for Nephrology, Dialysis and Transplantation, Clinical Centre Nis, University of Niš, Niš, Serbia.
  2. Clinic for Nephrology, Dialysis and Transplantation, Clinical Centre Nis, University of Niš, Niš, Serbia; Institute of Pathophysiology, University of Niš, Niš, Serbia.
  3. Institute of Pathophysiology, University of Niš, Niš, Serbia.
  4. Institute for Public Health, University of Niš, Niš, Serbia.
  5. Department of Internal Medicine, University of Niš, Niš, Serbia.
  6. Institute of Biochemistry, Medical Faculty, University of Niš, Niš, Serbia.

PMID: 26989395 PMCID: PMC4789923 DOI: 10.1159/000437309

Abstract

INTRODUCTION: Pathophysiological interaction between the heart and kidneys represents the basis for clinical entities called cardiorenal syndromes. The purpose of the study was to assess the relations between acute and chronic cardiorenal syndromes and biomarkers [advanced oxidation protein products, brain natriuretic peptide, malondialdehyde, xanthine oxidoreductase (XOD), xanthine oxidase, xanthine dehydrogenase, interleukin 8, cystatin C, plasminogen activator inhibitor-1, high-sensitive troponin T, C-reactive protein and glomerular filtration rate, measured by the Modification of Diet in Renal Disease (MDRD) formula], to hypothesize biomarkers that might provide a prompt identification of acute or chronic cardiorenal syndromes, and to distinguish acute versus chronic types of these syndromes.

METHODS: A total of 114 participants were enrolled in this study, i.e. 79 patients divided into subgroups of acute and chronic cardiorenal syndromes and 35 volunteers.

RESULTS: Nonadjusted odds ratio (OR) showed that there was a significant risk for acute cardiorenal syndrome with increased XOD activity (p = 0.037), elevated cystatin C concentration (p = 0.038) and MDRD (p = 0.028). Multivariable adjusted OR, on the other hand, revealed that only glomerular filtration rate measured by the MDRD formula had a significance for acute cardiorenal syndrome (p = 0.046). Nonadjusted OR showed a significant risk for chronic cardiorenal syndrome only in elderly (p = 0.002). Multivariable adjusted OR exhibited that age was the only risk factor for chronic cardiorenal syndrome (p = 0.012).

CONCLUSION: Cystatin C, glomerular filtration rate measured by the MDRD equation and XOD were independent risk factors for acute cardiorenal syndrome, while age remained an independent risk factor for chronic cardiorenal syndrome. When comparing ORs of evaluated parameters, the highest significance for acute cardiorenal syndrome was plasma concentration of cystatin C.

Keywords: Cardiorenal syndromes; Cystatin C; Modification of Diet in Renal Disease formula; Xanthine oxidoreductase

References

  1. Clin Chem Lab Med. 2002 Aug;40(8):752-60 - PubMed
  2. J Card Fail. 2011 Jan;17(1):31-8 - PubMed
  3. Crit Care Med. 2008 Jan;36(1 Suppl):S75-88 - PubMed
  4. Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S30-7 - PubMed
  5. Circulation. 2003 Mar 18;107(10):1383-9 - PubMed
  6. Kidney Int Suppl. 2003 May;(84):S11-4 - PubMed
  7. N Engl J Med. 2000 Jun 15;342(24):1792-801 - PubMed
  8. Kidney Int. 2009 Mar;75(6):652-60 - PubMed
  9. J Physiol. 2004 Mar 16;555(Pt 3):589-606 - PubMed
  10. Ann Intern Med. 2005 Apr 5;142(7):497-505 - PubMed
  11. Kidney Int. 2004 Apr;65(4):1416-21 - PubMed
  12. J Hypertens. 2001 Oct;19(10):1905-12 - PubMed
  13. Clin Chem. 2009 Nov;55(11):1932-43 - PubMed
  14. N Engl J Med. 2005 May 19;352(20):2049-60 - PubMed
  15. Lab Delo. 1988;(11):41-3 - PubMed
  16. Scand J Clin Lab Invest. 2005;65(2):153-62 - PubMed
  17. J Card Fail. 2008 Feb;14 (1):19-26 - PubMed
  18. Eur Heart J. 2010 Nov;31(22):2791-8 - PubMed
  19. Int J Artif Organs. 2008 Jan;31(1):1-2 - PubMed
  20. J Lab Clin Med. 1977 May;89(5):1135-44 - PubMed
  21. Contrib Nephrol. 2013;182:82-98 - PubMed
  22. Heart Fail Rev. 2012 Mar;17(2):241-50 - PubMed
  23. FEBS Lett. 1988 Aug 15;236(1):14-8 - PubMed

Publication Types